Tryp Therapeutics Inc.: Tryp Therapeutics Appoints Luke Hayes as Chief Financial Officer
Tryp Therapeutics Inc.: Tryp Therapeutics Appoints Luke Hayes as Chief Financial Officer Tryp" or the " Company"), a pharmaceutical company focused on identifying and developing clinical-stage compounds for diseases with high unmet medical needs, is pleased to announce that it has appointed Luke Hayes as its Chief Financial Officer. Mr. Hayes has been active in the life science industry for more than 20 years with experience in technology transfer, venture capital, and finance. He started his career doing business development for Dow Chemical with responsibility for pharmaceutical customers i...
Source: finanznachrichten.de